Lisdexamfetamine dimesylate had no apparent effects on embryo-fetal morphological development or survival when administered orally to pregnant rats and rabbits throughout the period of organogenesis at doses of up to 40 and 120 mg/kg/day, respectively. Before taking VYVANSE, tell your healthcare provider about all medical conditions, including if you or https://steved824ykx5.madmouseblog.com/profile